Your browser doesn't support javascript.
loading
Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery.
Resio, Benjamin J; Gonsalves, Lou; Canavan, Maureen; Mueller, Lloyd; Phillips, Cathryn; Sathe, Tejas; Swett, Katrina; Boffa, Daniel J.
Afiliación
  • Resio BJ; Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Gonsalves L; Connecticut Tumor Registry, Hartford, CT, USA.
  • Canavan M; Department of Internal Medicine, Cancer Outcomes and Public Policy and Effectiveness Research (COPPER), Yale School of Medicine, New Haven, CT, USA.
  • Mueller L; Connecticut Tumor Registry, Hartford, CT, USA.
  • Phillips C; Connecticut Tumor Registry, Hartford, CT, USA.
  • Sathe T; Yale School of Medicine, New Haven, CT, USA.
  • Swett K; Connecticut Tumor Registry, Hartford, CT, USA.
  • Boffa DJ; Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA. daniel.boffa@yale.edu.
Ann Surg Oncol ; 28(3): 1278-1286, 2021 Mar.
Article en En | MEDLINE | ID: mdl-32885398
BACKGROUND: Nearly half of operative mortalities occur outside the traditionally studied 30-day period after surgery. To identify additional opportunities to improve surgical safety, the circumstances of deaths occurring 31-90 days after complex cancer surgery are analyzed. PATIENTS AND METHODS: Patients aged ≥ 65 years who died within 90 days of complex cancer surgery for nonmetastatic cancer were analyzed in the Surveillance, Epidemiology, and End Results (SEER)-Medicare and the Connecticut Tumor Registry (CTR) databases. RESULTS: Of the 36,114 patients undergoing complex cancer surgery from 2004 to 2013 in SEER-Medicare, 1367 (3.8%) died within 31-90 days ("late mortalities"). Seventy-eight percent of late mortalities were readmitted prior to death. The highest proportion of late mortalities occurred during a readmission (49%), and 11% were never discharged from their index admission. Cause of death (COD) was largely attributed to the malignancy itself (56%), which is unlikely to be the underlying cause. Of the noncancer COD, cardiac causes were most frequent (34%), followed by pulmonary causes (18%). Death was rarely attributed to thromboembolic disease (< 1%). The CTR provided location of death, which was most commonly in a hospital (65%) or nursing facility (20%); death at home was rare (6%). CONCLUSIONS: The vast majority of patients dying between 31 and 90 days of surgery were admitted to a hospital or nursing facility at the time of their death after initially being discharged, and few patients died at home. Greater clarity in death documentation is needed to identify specific opportunities to rescue patients from fatal complications arising in the later postoperative period.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Readmisión del Paciente / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Readmisión del Paciente / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos